Imagine battling a condition that steals your confidence and disrupts your life. For many women with Polycystic Ovarian Syndrome (PCOS), this is a daily reality. But what if a controversial weight-loss drug, traditionally used for diabetes, could offer a solution – even in smaller, unconventional doses? This is the story of one woman's journey with Mounjaro and the growing trend of 'microdosing' GLP-1 medications. But here's where it gets controversial: is it a safe and effective approach, or a dangerous gamble with potentially unknown consequences?
Bec Laut, a PR founder, experienced the onset of PCOS symptoms – irregular cycles and acne – shortly after her first period at 15. Like many others, her initial treatment was the birth control pill. "It did help," Laut told the Daily Mail, "and I ended up staying on it consistently for about 17 years." The pill masked the symptoms, providing temporary relief. But this is the part most people miss: the underlying hormonal imbalance remained unaddressed.
Eventually, Laut decided to discontinue the pill, leading to a formal PCOS diagnosis within six months. "From there, it was about 18 months of trying to manage things naturally; eating well, training four times a week, managing stress (hard as a business owner) and yet my body just wouldn't respond," she explained. "The cystic acne and extreme hair loss really hit my confidence and mental health." It highlights a frustrating reality for many women with PCOS: lifestyle changes alone aren't always enough.
That's when Laut's doctor suggested a GLP-1 medication, such as Ozempic or Mounjaro, primarily to assist with weight loss, with the expectation that this would subsequently reverse insulin resistance and improve her PCOS symptoms. GLP-1 stands for glucagon-like peptide 1, a hormone that plays a crucial role in regulating blood sugar levels and appetite. These medications mimic this hormone, leading to reduced hunger and improved blood sugar control. But initially, Laut was hesitant. "Honestly, I brushed it off," she said. "At the time, it was being spoken about pretty negatively and I thought: I don't need that." The stigma surrounding weight-loss drugs and the fear of side effects are common barriers for many.
The rise of GLP-1 medications has undeniably transformed the Australian medical landscape. It's estimated that approximately 420,000 Australians are currently using these medications, and this number is projected to increase. Many users have experienced significant weight loss and a reduction in cardiovascular and metabolic risk factors, leading to improved overall health. But the increasing popularity also raises questions about accessibility, appropriate usage, and potential long-term effects.
What ultimately changed Laut's mind was the experience of a colleague who reported experiencing "mental clarity, faster recovery, and relief from severe PCOS symptoms." This anecdotal evidence sparked her interest. "Hearing that shifted my mindset," Laut said. "I decided to start the following February, and it's been life-changing since." While weight loss was a factor, the unexpected improvements in other PCOS-related symptoms were a game-changer for her.
However, Laut's journey wasn't without its challenges. While the medication led to significant body changes, she struggled with side effects. "About five months in, I noticed my weight continuing to drop, but my energy was really low." It's a reminder that even with positive outcomes, these medications can have adverse effects that need careful management. And this is where the concept of microdosing enters the picture.
Around this time, Laut learned about "microdosing," a technique involving smaller-than-prescribed doses to minimize side effects while still achieving desired health results. "I'd done some research and, more importantly, paid close attention to how my body felt," she explained. "So I went back to my doctor to discuss testing smaller doses under supervision. We adjusted my dosage, and now I take roughly half the standard weekly dose. It's been a sweet spot for me, the benefits without the burnout. I feel stable, clear, and more in tune with my body than I've been in years." Laut's experience highlights the potential for personalized medicine, where dosage is tailored to individual needs and responses.
Laut is part of a growing community of GLP-1 users experimenting with microdosing, often referring to themselves online as "click counters" due to the way they measure out the dose using the pen's clicks. But here's the catch: While Laut's approach is supervised by her doctor, many others may be self-treating based on anecdotal evidence found online, potentially ignoring professional medical advice. This raises serious concerns about safety and efficacy.
Dr. Terry-Lynne South, Chair of RACGP Specific Interests Obesity, expresses concern about this trend. "I think it would be very concerning for someone to be taking these medications for those perceived benefits that they're hearing about on social media, because there's just no proof as of yet," she warns. The lack of scientific evidence supporting the use of microdosing for off-label purposes is a major point of contention.
Online platforms like Reddit forums (e.g., r/GLP1microdosing) and TikTok hashtags (e.g., #MicroDoseGLP1 Australia) are filled with stories and advice from individuals claiming that microdosing has alleviated symptoms of various conditions, from PMDD to lipoedema and endometriosis. While Dr. South acknowledges that the field is rapidly evolving, she emphasizes that the evidence to support these claims is currently lacking. But, she also adds, "Having said that, there is a lot more research going into these GLP-1 injectable medications, and it is showing some improved benefits in areas of health that we would never have thought, including Parkinson's disease and some types of dementia, as well as alcohol addiction." This hints at the potential for future discoveries but underscores the need for rigorous scientific investigation.
Reel after reel of 'how-to' videos from members of the 'longevity' community on social media tout the benefits of GLP-1 medications, which South finds particularly concerning, given these creators' lack of medical knowledge. "I think that an evidence-free zone is concerning, because there are assumptions that there's going to be positive effects which are not yet proven, but we do actually know that all medications have risks and side effects," she continues. "And so I'd be concerned about known risks and side effects, but no proven benefits with regards to microdosing for off-label use." This highlights the importance of relying on credible sources of information and consulting with qualified healthcare professionals.
Queensland project manager Sarah Kuhne, who documents her GLP-1 journey on TikTok, shares a different perspective. While she primarily uses the medication for weight loss, she's experienced unexpected benefits in other areas. "I fall into the category of a 'super responder' because I've lost more than 40 per cent of my starting body weight now, which is double what you can 'expect' to lose," she says. "For me though it's been about so much more than weight loss – I've gained back mobility, my fitness, my willingness to actively play with my three-year-old daughter, and I no longer have to take blood pressure medication." Furthermore, she adds, "I have gone from the highest to lowest possible antidepressant dose (after 15 years) and it's reduced inflammation in my lipoedema in my legs and almost eradicated my endometriosis pain." Kuhne's experience underscores the potential for GLP-1 medications to have a wider impact on health beyond weight loss, although these outcomes can vary significantly from person to person.
While Kuhne currently takes the full recommended dose under medical supervision, she's open to the possibility of microdosing in the future. "I've read a lot about microdosing online, you see a lot of people talking about it in Reddit forums and on social media," she explains. "It's definitely something I would consider, the cost can be prohibitive, and if I could get the same benefits for a smaller dose, then it would be great." The high cost of these medications is a significant barrier for many, making microdosing an appealing option for those seeking to reduce expenses.
Dr. South acknowledges the rationale behind this thinking but strongly advises individuals to consult with their doctor before altering their dosage. "The reason it's so important to make sure you stay under a doctor's guidance is because it depends so heavily on what that individual's health goals are," she explains. "I'll give you an example. Particularly with the higher dose Semaglutide 2.4 [brand name Wegovy] it's TGA-approved for what we call 'secondary cardiovascular risk protection'. So it's for people who already have heart health problems, preventing them from having second events, and the research is looking at that dose of 2.4 – so I cannot say that a lower dose than 2.4 would have that same cardio-protective effect." She emphasizes that the optimal dosage depends on individual health goals and the specific benefits being sought.
South advises consulting with a doctor who understands your holistic health goals – and the mechanisms of the medicine itself – before making any changes. Ultimately, the decision to use GLP-1 medications, including the potential for microdosing, should be made in consultation with a qualified medical professional. What do you think? Is microdosing GLP-1 medications a promising approach for managing PCOS and other conditions, or a risky trend that needs more scientific scrutiny? Share your thoughts and experiences in the comments below!
